Yan Y - Search Results

1

Mesenchymal stem cells overexpressing IL-35 effectively inhibit CD4⁺ T cell function.

Zhao N, Li H, Yan Y, Jiang R, He X. Zhao N, et al. Among authors: yan y. Cell Immunol. 2017 Feb;312:61-66. doi: 10.1016/j.cellimm.2016.12.001. Epub 2016 Dec 8. Cell Immunol. 2017. PMID: 27993351

2

Evidence of cell fusion in carcinogen-induced mice gastric carcinoma.

Yan Y, Hsu Y, He X, Lu N, Wei W, Zhang Z, Zhu L. Yan Y, et al. Tumour Biol. 2015 Jul;36(7):5089-94. doi: 10.1007/s13277-015-3160-5. Epub 2015 Feb 6. Tumour Biol. 2015. PMID: 25656611

3

Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level.

Wang W, Guo H, Li H, Yan Y, Wu C, Wang X, He X, Zhao N. Wang W, et al. Among authors: yan y. Hum Gene Ther. 2018 Feb;29(2):234-241. doi: 10.1089/hum.2017.171. Epub 2017 Oct 20. Hum Gene Ther. 2018. PMID: 29054137

4

Mesenchymal stem cell expression of interleukin-35 protects against ulcerative colitis by suppressing mucosal immune responses.

Yan Y, Zhao N, He X, Guo H, Zhang Z, Liu T. Yan Y, et al. Cytotherapy. 2018 Jul;20(7):911-918. doi: 10.1016/j.jcyt.2018.05.004. Epub 2018 Jun 12. Cytotherapy. 2018. PMID: 29907361

5

Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.

Wang W, Zhao N, Li B, Gao H, Yan Y, Guo H. Wang W, et al. Among authors: yan y. Scand J Immunol. 2019 Apr;89(4):e12750. doi: 10.1111/sji.12750. Epub 2019 Feb 11. Scand J Immunol. 2019. PMID: 30664805 Free article.

6

Selection and expression of CD40 single chain variable fragment by phage display and evaluation of tumor specific immune activation.

Lu L, Wang X, Zhang A, Huang F, Yan Y, Li W, Fu W. Lu L, et al. Among authors: yan y. Int Immunopharmacol. 2019 Jun;71:224-232. doi: 10.1016/j.intimp.2019.03.020. Epub 2019 Mar 26. Int Immunopharmacol. 2019. PMID: 30925323

7

A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions.

Lu L, Liu N, Fan K, Zhang G, Li C, Yan Y, Liu T, Fu WH. Lu L, et al. Among authors: yan y. Mol Immunol. 2019 May;109:149-156. doi: 10.1016/j.molimm.2019.03.001. Epub 2019 Apr 2. Mol Immunol. 2019. PMID: 30951934

8

RGS4 promotes the progression of gastric cancer through the focal adhesion kinase/phosphatidyl-inositol-3-kinase/protein kinase B pathway and epithelial-mesenchymal transition.

Chen PY, Wang PY, Liu B, Jia YP, Zhang ZX, Liu X, Wang DH, Yan YJ, Fu WH, Zhu F. Chen PY, et al. World J Gastroenterol. 2025 Jan 14;31(2):100898. doi: 10.3748/wjg.v31.i2.100898. World J Gastroenterol. 2025. PMID: 39811500 Free PMC article.

9

Potential Role of EBI3 in Gastric Cancer and Its Inductive Effects on T Cell Exhaustion.

Yan Y, Shen Z, Woo Y, Wang D, Liu X, Zhang W, Zhang Z, Wang P, Fu W. Yan Y, et al. J Am Coll Surg. 2024 Dec 19. doi: 10.1097/XCS.0000000000001263. Online ahead of print. J Am Coll Surg. 2024. PMID: 39699043

10

T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review).

Zhang Z, Zhang W, Liu X, Yan Y, Fu W. Zhang Z, et al. Among authors: yan y. Oncol Lett. 2024 Sep 6;28(5):537. doi: 10.3892/ol.2024.14670. eCollection 2024 Nov. Oncol Lett. 2024. PMID: 39319215 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,810 results

Search Page

Filters